# Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)

> **NCT00979901** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1577 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Comparator: montelukast
- **DRUG:** Comparator: loratadine
- **DRUG:** Comparator: placebo
- **DRUG:** Comparator: montelukast/loratadine

## Key facts

- **NCT ID:** NCT00979901
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-03
- **Primary completion:** 2000-05
- **Final completion:** 2000-05
- **Target enrollment:** 1577 (ACTUAL)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979901, "Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00979901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*